Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2013

Allied Healthcare Group (BOMDF) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 9, 2013 by Mission IR

Allied Healthcare Group is a diversified healthcare company focused on investing in next generation technologies, acquiring strategic assets to grow its product and service offerings. BOMDF operates in three businesses: Cordion, focused on vaccine technology for the prevention of infectious … Continue reading →

Posted in EBD Group Conference | Leave a comment

NewLead Holdings Ltd. (NEWL) Receives $236.4 Million Investment

Posted on January 9, 2013 by MissionIR

NewLead Holdings is an international, vertically integrated shipping and commodity company that manages double-hull product tankers and dry bulk vessels. The company currently controls four vessels, two tankers, and two dry bulk ships. The company announced today it received a … Continue reading →

Posted in Small Cap News | Leave a comment

TNI BioTech, Inc. (TNIB) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 9, 2013 by Mission IR

TNI BioTech is a biotech company engaged in combating fatal diseases through activating and mobilizing the body’s immune system using the company’s patented immunotherapy. The company’s products and immunotherapy technologies are designed to harness the power of the immune system … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Medtronic Neuromodulation (MDT) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 9, 2013 by Mission IR

Medtronic Neuromodulation is the second-oldest and fourth-largest business unit of Medtronic, Inc., the world’s leader in medical technology. Neuromodulation was formed as the company transferred its expertise in heart electrical stimulation for the treatment of diseases and conditions involving the … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Aradigm Corp. (ARDM) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 9, 2013 by Mission IR

Aradigm is engaged in developing inhalation drug products designed to improve the quality of life of patients with severe pulmonary disease. The company’s lead development candidates are formulations of the potent antibiotic ciprofloxacin (Pulmaquin (ARD-3150) and Lipoquin (ARD-3100), which is … Continue reading →

Posted in EBD Group Conference | Leave a comment

Circadian Technologies Ltd. (CKDXF) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 9, 2013 by Mission IR

Circadian Technologies is engaged in angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs), the company seeks to develop truly novel therapies to extend and improve the lives of cancer sufferers. The … Continue reading →

Posted in EBD Group Conference | Leave a comment

Bacterin International Holdings, Inc. (BONE) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 9, 2013 by Mission IR

Bacterin International Holdings is a developer, manufacturer and marketer of biologics products to domestic and international markets. The company’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold – promoting bone, subchondral repair … Continue reading →

Posted in OneMedForum Conference | Leave a comment

InVivo Therapeutics (NVIV) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 9, 2013 by Mission IR

InVivo Therapeutics is focused on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). The company’s aim is to develop/commercialize biocompatible polymer scaffolding devices to treat acute spinal cord injuries; biocompatible hydrogel to treat acute spinal cord … Continue reading →

Posted in EBD Group Conference | Leave a comment

ImmunoCellular Therapeutics (IMUC) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 9, 2013 by Mission IR

ImmunoCellular Therapeutics is a clinical-stage biotech company focused on the development of novel immune-based products for the treatment of cancer. The product candidate portfolio includes cellular immunotherapies targeting cancer and cancer stem cell antigens, peptide based immunotherapies targeting cancer stem … Continue reading →

Posted in EBD Group Conference | Leave a comment

Tvax Biomedical Inc. (TVAX) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 9, 2013 by Mission IR

Tvax Biomedical is a clinical stage drug development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. The company’s lead candidates, focused on treating brain and kidney cancer, are supported by positive phase 2 clinical data and … Continue reading →

Posted in EBD Group Conference | Leave a comment